Representational photo of Bangavax Covid-19 vaccine Dhaka TribuneBMRC considering allowing two more vaccines -- one from China another from India -- for human trialsThe Bangladesh Medical Research Council (BMRC) has decided to give a fresh set of conditions to Globe Biotech Limited for the human trials of the homegrown Bangavax coronavirus vaccine. The three companies – one from China, one from India and one being Globe Biotech – had applied to us before,” he said. When asked about the progress regarding Bangavax, the BMRC director said that Globe Biotech would need to complete a number of processes, including applying the vaccine on monkeys or chimpanzees before proceeding to human trials. Earlier on December 28 last year, the Directorate General of Drug Administration (DGDA) permitted Globe Biotech to manufacture Bangavax for clinical trials. On December 1, Globe Biotech announced that it would part ways with the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) on conducting human trials of its vaccine.

Source: Dhaka Tribune June 16, 2021 09:56 UTC